Michael H Gold
Overview
Explore the profile of Michael H Gold including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
315
Citations
2374
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
2.
Tseng F, Vachiramon V, Gold M, Pavicic T, Tay C, Toh G, et al.
J Cosmet Dermatol
. 2024 Dec;
24(2):e16686.
PMID: 39645606
Background: Immunoresistance to botulinum neurotoxin A (BoNT-A) due to neutralizing antibodies (NAbs) can lead to partial or complete secondary nonresponse (SNR), potentially limiting individuals' aesthetic and/or medical therapeutic options in...
3.
Singh N, Brown A, Gold M
J Cosmet Dermatol
. 2024 Nov;
24(2):e16673.
PMID: 39552100
Background: With the ever-changing cosmetic landscape, Ayurvedic skincare, rooted in the holistic medical system of Ayurveda from India, has gained popularity in Western countries due to its natural ingredients and...
4.
Rashied R, Gold M
Dermatol Clin
. 2024 Nov;
43(1):55-66.
PMID: 39542564
This study aims to analyze and discuss recent trials of high-dose and liquid toxins for treating moderate to severe glabellar lines. A comprehensive review of clinical studies and patient outcomes...
5.
Gold M, Numani A, Dasgupta A, Wyles S
Dermatol Surg
. 2024 Oct;
50(11S):S177-S179.
PMID: 39480042
No abstract available.
6.
Maloney M, Iglesia S, Kononov T, Zahr A, Gold M
J Cosmet Dermatol
. 2024 Oct;
23(12):4077-4084.
PMID: 39385645
Background: Radiofrequency (RF) microneedling produces patient discomfort which deters patients from completing the recommended treatment series. Objective: The primary objective was to determine the tolerability, safety, and efficacy of a...
7.
Mysore V, Deepthi M, Chandrashekar B, Shah S, Gold M, Shivani S, et al.
J Cosmet Dermatol
. 2024 Sep;
23(12):3809-3820.
PMID: 39233487
Background: Lasers and other energy-based devices are increasingly becoming popular in aesthetic practice. Many centers employ doctors or technicians to perform these procedures where treating doctor and operating doctor may...
8.
Zhang X, Teng C, Bai X, Teng J, Chilukuri S, Lewis A, et al.
J Cosmet Dermatol
. 2024 Jul;
23(12):4043-4050.
PMID: 39083431
Background: Recent advancements in dermatological therapeutics have highlighted the need for treatments that enhance skin regeneration and healing. Diamond-Augmented Zinc Oxide (ND-ZnO) technology combines zinc oxide with diamond particles in...
9.
Fluhr J, F Alexis A, Andriessen A, Ferero Barrios O, Bjerring P, Foley P, et al.
Int J Dermatol
. 2024 Jul;
63(12):1676-1684.
PMID: 39073154
Xerosis is highly prevalent in the population aged over 50 years and substantially impacts quality of life due to the associated stigma, related pruritus, and potential sequelae. We propose that...
10.
Shridharani S, Moradi A, Donofrio L, Gold M, Biesman B, Chiang M, et al.
Aesthet Surg J
. 2024 Jun;
44(12):1330-1340.
PMID: 38913088
Background: RelabotulinumtoxinA (RelaBoNT-A, Galderma, Uppsala, Sweden) is an innovative, ready-to-use liquid botulinum toxin A, produced with PEARL (precipitation-free extraction and activity-preserving refined liquid) manufacturing technology, which yields a potent, complex-free...